Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

olanzapine 15 MG Disintegrating Oral Tablet

Known as: OLANZAPINE 15MG,TAB RAPID DISINTEGRATING [VA Product], OLANZAPINE 15 mg ORAL TABLET, ORALLY DISINTEGRATING [Olanzapine], Olanzapine 15 mg ORAL TABLET, ORALLY DISINTEGRATING 
National Institutes of Health

Related topics

Related topics

33 relations
Adrenergic alpha-Antagonists [MoA]Antipsychotic AgentsAspartameBenzyl Alcohol
Expand

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Application of plasma levels of olanzapine and N-desmethyl-olanzapine to monitor metabolic parameters in patients with schizophrenia
Metabolic disturbance is a common side effect of olanzapine (OLZ); however, the relationships between plasma OLZ concentration… 
2014
2014
Long-term functional improvements in the 2-year treatment of schizophrenia outpatients with olanzapine long-acting injection
Background Little is known about the long-term changes in the functioning of schizophrenia patients receiving maintenance therapy… 
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
2014
2014
Incidences of extrapyramidal symptoms in patients with schizophrenia after treatment with long-acting injection (depot) or oral formulations of olanzapine.
BACKGROUND The incidence of extrapyramidal symptoms (EPS) has been shown to be generally low among patients with schizophrenia… 
2013
2013
Predictors of psychiatric hospitalization during 6 months of maintenance treatment with olanzapine long-acting injection: post hoc analysis of a randomized, double-blind study
BackgroundHospitalization is a costly and distressing event associated with relapse during schizophrenia treatment. No… 
  • table 1
  • table 2
  • figure 1
  • table 3
Review
2013
Review
2013
Author ' s response to reviews Title : Predictors of psychiatric hospitalization during 6 months of maintenance treatment with olanzapine long-acting injection : post hoc analysis of a randomized…
Background: Hospitalization is a costly and distressing event associated with relapse during schizophrenia treatment. No… 
Review
2012
Review
2012
Effects of olanzapine long-acting injection on levels of functioning among acutely ill patients with schizophrenia
Abstract Objective: To assess the effects of olanzapine long-acting injection (olanzapine-LAI) on levels of functioning in… 
Review
2010
Review
2010
Long-acting injectable antipsychotics: focus on olanzapine pamoate
  • J. Lindenmayer
  • Neuropsychiatric disease and treatment
  • 2010
  • Corpus ID: 1769683
Medication non-adherence in patients with schizophrenia continues to be a significant problem and threatens successful treatment… 
Highly Cited
2004
Highly Cited
2004
A study of matrix effects on an LC/MS/MS assay for olanzapine and desmethyl olanzapine.
The purpose of this research project was to investigate potential matrix effects of anticoagulant and lipemia on the response of… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE